Anti-Human CEACAM8/CD66b Rabbit Recombinant Antibody

CEACAM8/CD66b Uni-rAbTM Recombinant Antibody for FC
Cat No. 98507-2-RR

产品说明书

CloneNo. 242954D11

宿主/亚型

Rabbit / IgG

种属反应性

human

应用

FC

CD66b, CEACAM8, Carcinoembryonic antigen CGM6, Carcinoembryonic antigen-related cell adhesion molecule 8, CD 66b

缓冲液配方:  PBS and Azide
PBS and Azide
PBS Only
偶联物:  Unconjugated
Unconjugated
规格价格库存


经过测试的应用

Positive FC detected inhuman peripheral blood leukocytes

推荐稀释比

应用推荐稀释比
Flow Cytometry (FC)FC : 0.25 ug per 10^6 cells in a 100 µl suspension
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

98507-2-RR targets CEACAM8/CD66b in FC applications and shows reactivity with human samples.

经测试应用 FC Application Description
经测试反应性 human
免疫原 CEACAM8/CD66b fusion protein Eg32133 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Recombinant
产品类型 Antibody
全称 carcinoembryonic antigen-related cell adhesion molecule 8
别名 CD66b, CEACAM8, Carcinoembryonic antigen CGM6, Carcinoembryonic antigen-related cell adhesion molecule 8, CD 66b
计算分子量 38 kDa
GenBank蛋白编号BC026263
基因名称 CEACAM8
Gene ID (NCBI) 1088
偶联类型 Unconjugated
形式 Liquid
纯化方式Protein A purification
UNIPROT IDP31997
储存缓冲液 PBS with 0.09% sodium azide, pH 7.3.
储存条件Store at 2 - 8°C. Stable for one year after shipment.

背景介绍

Carcinoembryonic antigen-related cell adhesion molecule 8 (CEACAM8), also known as CD66b, CGM6 or NCA-95, is a member of the cacinoembryonic antigen (CEA) family which belongs to the immunoglobulin superfamily of cell adhesion molecules (PMID: 16919437). CEACAM8 is a glycosylphosphatidylinositol (GPI)-linked glycoprotein expressed on granulocytes (PMID: 8104998; 18056392). It is involved in regulating adhesion and activation of eosinophils (PMID: 18056392).

实验方案

Product Specific Protocols
FC protocol for CEACAM8/CD66b antibody 98507-2-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...